Patent · US Active

Recombinant AAV variants and uses thereof

US11542525B2 · kind B2 · utility

1Cited by

68References

20Claims

0Family size

Assignee

University of Massachusetts · US

Inventors

Guangping Gao · Rosemont, US
Jun Xie · Singapore, SG
Terence Flotte · Holden, US

Key dates

Filing date	Sep 26, 2019
Grant date	Jan 3, 2023
Priority date	—
Expiry date	Mar 27, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/008
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the disclosure relates to gene transfer methods using the recombinant adeno-associated viruses. In some aspects, the disclosure relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.